Mike Fillon. Show Affiliations »
Abstract
Mesh： See more » Advertising/methodsAdvertising/statistics & numerical dataAdvertising/trendsCalifornia/epidemiologyElectronic Nicotine Delivery Systems/adverse effectsElectronic Nicotine Delivery Systems/psychologyElectronic Nicotine Delivery Systems/standardsElectronic Nicotine Delivery Systems/statistics & numerical dataElectronic Nicotine Delivery Systems/trendsGuidelines as Topic/standardsHealth EducationHealth Policy/legislation & jurisprudenceHealth Policy/trendsHumansNicotine/administration & dosageNicotine/adverse effectsNicotinic Agonists/administration & dosageNicotinic Agonists/adverse effectsPublic Policy/legislation & jurisprudencePublic Policy/trendsSmoking/trendsSmoking Cessation/psychologySmoking PreventionSocial MarketingSubstance-Related Disorders/etiologySubstance-Related Disorders/prevention & controlSurveys and QuestionnairesUnited States/epidemiology
Substances： See more » Nicotinic AgonistsNicotine
Year: 2015 PMID： 26142445 DOI： 10.1093/jnci/djv192
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506